Company profile
ProtoKinetix, Inc. CIK 1128189
Ticker
PKTX
Industry
Pharmaceutical Preparations
Headquarters
Dalton, OH 44618
Fiscal year end
2025 (FY)
Key Financials
Revenue
—
Net income
-$393.7K
Total assets
$483.4K
Total liabilities
—
Stockholders' equity
$297.9K
Cash & equivalents
$1.1K
Operating income
—
Operating cash flow
-$135.4K
Capital expenditures
—
Fiscal year 2025, via 10-K filed 2026-09-03. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
—
Equity / assets
61.6%
CapEx / revenue
—
Operating cash flow / net income
0.34×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
—
-$393.7K
$483.4K
—
$297.9K
2024
—
-$364.2K
$466.1K
—
$342.1K
2023
—
-$415.5K
$480.6K
—
$435.9K
2022
—
-$1.91M
$462.9K
—
$421.3K
2021
—
-$2.33M
$446.2K
—
$353.0K
Company Details
SIC code
2834
State of incorporation
NV
Active filer
Yes
Most recent SEC filing
Form 10-K
2026-09-03
Financials filed via
Form 10-K
filed 2026-09-03
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Dalton, OH 44618
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:50 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.